News Industry News Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease May 23, 2018
News Industry News STENTYS Completes Enrollment in the Study Assessing the Safety and Efficacy of Xposition S in Left Main Artery Lesions July 28, 2017
News Industry News STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention February 28, 2016
News Industry News Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study September 01, 2015
News Industry News First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate) July 29, 2015
News Industry News Minneapolis Heart Institute® Physician Serves as National PI in Research Trial Aiming to Improve Outcomes for Those with Peripheral Arterial Disease July 21, 2015
News Industry News Blue Cross Blue Shield Association Study Reveals Significant Cost Variations for Angioplasties July 17, 2015
News Industry News The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA June 25, 2015
News Industry News STENTYS: First Clinical Experience with Xposition shows 100% implantation success, Confirms Ease of Use May 20, 2015
News Industry News New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years May 19, 2015
News Industry News Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease May 19, 2015
News Industry News STENTYS starts clinical trial to broaden portfolio with new drug-eluting stent June 14, 2012
News Industry News NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications July 18, 2011
News Industry News Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V® April 03, 2011